Frew JW - Search Results

1

Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis.

Pham JP, Rosenø NAL, Roccuzzo G, Saal RC, Egeberg A, Ring HC, Frew JW. Pham JP, et al. Among authors: frew jw. J Am Acad Dermatol. 2024 Jul;91(1):170-172. doi: 10.1016/j.jaad.2024.03.028. Epub 2024 Mar 28. J Am Acad Dermatol. 2024. PMID: 38554939 Free article. No abstract available.

2

Diffuse melanosis cutis: a systematic review of the literature.

Sebaratnam DF, Venugopal SS, Frew JW, McMillan JR, Finkelstein ER, Martin LK, Murrell DF. Sebaratnam DF, et al. Among authors: frew jw. J Am Acad Dermatol. 2013 Mar;68(3):482-8. doi: 10.1016/j.jaad.2012.08.018. Epub 2012 Dec 6. J Am Acad Dermatol. 2013. PMID: 23219556 Review.

3

A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa.

Frew JW, Vekic DA, Woods J, Cains GD. Frew JW, et al. Br J Dermatol. 2017 Oct;177(4):987-998. doi: 10.1111/bjd.15441. Epub 2017 Sep 20. Br J Dermatol. 2017. PMID: 28278367 Review.

4

Drug-associated hidradenitis suppurativa: A systematic review of case reports.

Frew JW, Vekic DA, Woods JA, Cains GD. Frew JW, et al. J Am Acad Dermatol. 2018 Jan;78(1):217-219.e2. doi: 10.1016/j.jaad.2017.08.046. J Am Acad Dermatol. 2018. PMID: 29241794 Review. No abstract available.

5

Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.

Vekic DA, Frew J, Cains GD. Vekic DA, et al. Australas J Dermatol. 2018 Nov;59(4):267-277. doi: 10.1111/ajd.12770. Epub 2018 Jan 21. Australas J Dermatol. 2018. PMID: 29355905 Review.

6

Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.

Phan K, Tatian A, Woods J, Cains G, Frew JW. Phan K, et al. Among authors: frew jw. Int J Dermatol. 2020 Feb;59(2):221-228. doi: 10.1111/ijd.14697. Epub 2019 Oct 20. Int J Dermatol. 2020. PMID: 31631340

7

Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials.

Frew JW. Frew JW. J Am Acad Dermatol. 2020 Aug;83(2):663-665. doi: 10.1016/j.jaad.2020.03.078. Epub 2020 Apr 2. J Am Acad Dermatol. 2020. PMID: 32247874 Free PMC article. No abstract available.

8

Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic.

Frew JW. Frew JW. Br J Dermatol. 2021 Oct;185(4):696-697. doi: 10.1111/bjd.20513. Epub 2021 Jun 15. Br J Dermatol. 2021. PMID: 34131898 No abstract available.

9

Antimicrobial peptides in hidradenitis suppurativa: a systematic review.

Yao Y, Frew JW, Thomsen SF, Ring HC. Yao Y, et al. Among authors: frew jw. Br J Dermatol. 2022 Feb;186(2):236-244. doi: 10.1111/bjd.20750. Epub 2021 Nov 2. Br J Dermatol. 2022. PMID: 34498267 Review.

10

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.

Naik HB, Alhusayen R, Frew J, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA. Naik HB, et al. J Am Acad Dermatol. 2022 Jan;86(1):249-252. doi: 10.1016/j.jaad.2021.09.016. Epub 2021 Sep 16. J Am Acad Dermatol. 2022. PMID: 34537252 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page